Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: J Mol Biomark Diagn. 2012 Feb;Suppl 3:001. doi: 10.4172/2155-9929.S3-001

Figure 2.

Figure 2

A) Urine NMR spectra in the region from 2.48–2.41 ppm containing a carnitine-specific multiplet for all patients on DOL 8. NMR spectra for three patients displaying elevated carnitine levels are shown at the top.